<DOC>
	<DOCNO>NCT00725439</DOCNO>
	<brief_summary>This study look new oral drug treat acne . All patient study get active drug , placebo arm .</brief_summary>
	<brief_title>An Open Label Trial Assess Safety Efficacy Oral R115866 Treatment Facial Acne</brief_title>
	<detailed_description />
	<mesh_term>R 115866</mesh_term>
	<criteria>Male subject Presence moderate severe facial acne vulgaris : minimum 15 papule and/or pustule least 2 nodulocystic lesion In good general health free disease state physical condition , investigator 's opinion , might impair evaluation acne expose subject unacceptable risk trial participation Subjects type acne acne vulgaris Significant coexisting hepatic , renal , bone marrow disease , hyperlipidemia , chronic pancreatitis , osteoporosis , history indicate adrenal cortex dysfunction serious disease ( include cancer subject know HIV positive ) History malignancy past 5 year , except adequately treat basal cell carcinoma skin History heart failure , myocardial infarction within past six month , cardiac arrhythmia , treatment heart disorder Clinically significant abnormal ECGintervals morphology ECG ; QT QTc &gt; 470 m female &gt; 450 m male Use vitamin A ( &gt; 1000 microgram/day ) , phenytoin , carbamazepine , warfarin , rifampicin , tetracycline , ketoconazole , itraconazole , astemizole , terfenadine , cisapride , antipsychotic , antidepressant , lithium , antimalarial , alphablocking drug , angiotensinconverting enzyme inhibitor , cyclosporin A , glucocorticosteroids nonsteroid antiinflammatory drug , nonpotassiumsparing diuretic Use oral retinoids 6 month prior Visit 1 Use oral/topical therapy acne unless stop Visit 1 Use ultraviolet light ( include artificial UVA UVB well excessive natural sun exposure ) unless stop Visit 1</criteria>
	<gender>Male</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>September 2011</verification_date>
</DOC>